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Khusrow Niazi, MDSEE PAGE 472L ong chronic total occlusions are a formidablechallenge for endovascular recanalization. Pa-tients with critical limb ischemia are at a
greater risk of developing advanced disease along
with chronic total occlusions requiring revasculariza-
tion to avoid amputation (1). Over the years, different
endovascular techniques have been used to cross
long chronic total occlusions. Subintimal recan-
alization was serendipitously discovered and ﬁrst
reported by Bolia et al. (2) in 1989, when the athero-
sclerotic plaque, occluding the lumen, was crossed
by circumventing the plaque via the subintimal space
using a wire and catheter. This technique is also
known as percutaneous intentional extraluminal
recanalization (PIER) (3). Histological analysis of ves-
sels that had undergone subintimal recanalization
demonstrated that the dissection plane was between
the internal elastic lamina and the occlusive plaque
(4). The space is dilated with a balloon that communi-
cates with the true lumen distal to the occlusion,
thereby establishing ﬂow. Despite establishing ﬂow
and high limb salvage rates, the nemesis has been
the high rate of restenosis with subintimal recanaliza-
tion. Primary patencies ranging from 45% to 70% at
1 year, with further decrements over time (5,6). The
availability of nitinol stents, in conjunction with
this new channel technique created by subintimal
recanalization, has improved long-term patency.
The excitement of the ﬁrst-generation nitinol
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lectures from Covidien.term patency, especially when multiple stents were
used to treat long lesions or when stent fractures
happened (7). Second-generation stents became
available in longer lengths to reduce the use of mul-
tiple stents. Stent design has evolved to reduce the
incidence of fractures but has not completely pre-
vented them (8). These stents have demonstrated
superiority in long-term patency when compared
with balloon angioplasty in complex long lesions (9).
The endovascular approach has to overcome 3 main
challenges when confronting chronic total occlusions:
1) crossing the lesion; 2) establishing a lumen; and 3)
long-term patency.In this issue of JACC: Cardiovascular Interventions,
Hong et al. (10) have retrospectively evaluated
patency, utilizing spot stenting versus long stenting,
after an intentional subintimal approach for long
chronic total occlusions of the femoropopliteal ar-
teries. Of 163 patients with chronic total occlusions,
196 limbs were recanalized successfully. Of these, 129
limbs (66%) with spot stenting were compared with
67 limbs (34%) with long stenting. Restenosis of 29%
in the spot-stenting group and 45% in the long-
stenting group (p ¼ 0.001) with a median follow-up
of 1.7 years was noted. Multivariate analysis showed
long stenting, nonuse of clopidogrel or of cilostazol,
distal runoff vessels #1, small stent diameter, lower
post-procedural ankle-brachial index, and stent
coverage of the popliteal artery (especially when
extending to the tibial plateau or below) increased the
risk of restenosis. Because this was a retrospective
study, the choice of long- versus spot-stent strategy
was not randomized but was at the discretion of the
operator, creating selection bias. In the long-stent
group, the vessel diameter (5.8  0.9 mm and 6.2 
1.0 mm, p # 0.01) and stent size (6.5  0.5 mm and
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4827.3  0.7 mm, p # 0.001) were smaller than in the
spot-stent group.
Also, it is possible that the long-stenting strategy
was opted for when the subintimal track was more
diffusely diseased. Similar to Hong et al. (10),
others have shown that patency is related to the
length of the stent used (11,12). They report the
subintimal recanalization was “intentional,” but this
was not conﬁrmed with intravascular ultrasound.
The complexity of these long lesions mixed with
varying degrees of calciﬁcation and shrinkage of the
chronically occluded vessel (13) may cause the
crossing wire/catheter to travel back and forth from
“true” lumen to subintima without the operator
knowing. This has been shown to impact long-term
patency (14). There have been no comparison
studies assessing patency utilizing subintimal re-
canalization versus “true” lumen recanalization.
Finally, only 39% of the limbs were evaluated for
stent fracture, and in the ones evaluated, long
stenting had 9 of 27 (33%) fractures as compared
with spot stenting (11 of 49 [22%]). Will these data of
long stenting versus spot stenting hold true for thenewer generation of stents, which are longer and
have been shown to be less prone to fractures? In
conclusion, Hong and his team (10) should be
congratulated for bringing forth an important prac-
tical challenge faced in clinical practice for the
treatment of long lesions (25  8 cm) and complex
lesions (94% were in TransAtlantic Inter-Societal
Consensus TASC II C/D). This is a population that is
excluded from many trials. Prospective randomized
studies are warranted for complex chronic total oc-
clusions to compare subintimal recanalization to
“true” lumen recanalization and to identify factors
favoring long-term patency. Acute patency is being
achieved with balloons, stents and atherectomy, but
how these devices impact long-term results needs to
be identiﬁed. Finally, the efﬁcacy of drug-eluting
balloons added to the use of these devices needs
further study (15–18).
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